Allergy Therapeutics PLC (LSE:AGY) - Share price


Stock Report

Allergy Therapeutics PLC AGY

Last Price
GBX10.85

Day Change
0.00|0.00%

As of 06/12/2019
15:19:41 GMT | GBX
Minimum 15 Minutes Delay.

Last Close10.85p
Day Range10.70 - 11.00
Mkt Cap69.02Mil
52-Wk Range8.00 - 15.70
Yield %-
ISINGB00B02LCQ05
Volume53,263
P/E20.88
P/S0.01
P/CF0.13

Share Price

Total Returns 06/12/2019

 Chg (%)  
More ...
Allergy Therapeutics PLC-8.05 
FTSE 100 TR GBP-1.68
 
Financials
201720182019
More ...
Income Statement
Turnover64.1468.3573.72
Operating Profit-1.90-6.734.39
Net Profit-2.48-7.533.47
Reported EPS-0.42-1.270.52
Balance Sheet
Current Assets37.4630.9346.63
Non Current Assets19.7220.0921.87
Total Assets57.1851.0268.50
Current Liabilities14.0214.6316.86
Total Liabilities---
Total Equity29.9723.0337.56
Cash Flow
Operating Cash Flow1.28-4.175.38
Net Change in Cash-1.95-6.6011.79

Company Profile

Allergy Therapeutics PLC is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 06/03/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)21.15
Div Yld (E)0.00
PEG (E)0.00
ROCE8.70
Op Mrgn0.06
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Babatunde Adekunle Otulana
Non-Executive Director, ChairmanMr. Peter Sinclair Jensen
Non-Executive Director, Senior Independent DirectorMr. Stephen Rushworth Smith
Executive Director, Chief Executive OfficerMr. Manuel Llobet
Executive Director, Finance DirectorMr. Nicolas Alexander Ulrich Wykeman
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.